{
    "2021-10-27": [
        [
            {
                "time": "2021-Q3",
                "original_text": "贝达药业：前三财季盈利3.47亿人民币，同比减少37.02% 盈利能力下降",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "盈利",
                        "同比下降",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-Q3",
                "original_text": "贝达药业(300558.SZ)：前三季度扣非净利润升21.09%至3.26亿元",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "扣非净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-Q3",
                "original_text": "贝达药业公布三季报 前三季净利减少32.5% 盈利能力下降",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "三季报",
                        "净利减少",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-Q3",
                "original_text": "贝达药业(300558.SZ)前三季度归母净利同比降32.50%至3.47亿元 盈利能力下降",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "归母净利",
                        "同比下降",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-Q3",
                "original_text": "图解贝达药业三季报：第三季度单季净利润同比减64.39%",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "三季报",
                        "单季净利润",
                        "同比下降"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-Q3",
                "original_text": "贝达药业：2021年第三季度净利润约1.32亿元，同比下降64.39% 盈利能力下降",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "净利润",
                        "同比下降",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-Q3",
                "original_text": "贝达药业MRX2843急性髓系白血病I期临床研究首例受试者入组",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "MRX2843",
                        "急性髓系白血病",
                        "I期临床研究",
                        "首例受试者入组"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "研发"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-Q3",
                "original_text": "贝达药业：前三季度净利润同比减少32.5% 盈利能力下降",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "净利润",
                        "同比减少",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}